Seres Therapeutics Inc MCRB:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:35 AM EDT
0.58quote price arrow down-0.0053 (-0.9072%)
Volume
13,964
Close
0.5842quote price arrow down-0.0431 (-6.8707%)
Volume
3,703,378
52 week range
0.58 - 6.73
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.5842
  • 52 Week High6.73
  • 52 Week High Date04/25/23
  • 52 Week Low0.58
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap88.22M
  • Shares Out151.01M
  • 10 Day Average Volume4.41M
  • Dividend-
  • Dividend Yield-
  • Beta2.29
  • YTD % Change-58.27

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.5842
  • 52 Week High6.73
  • 52 Week High Date04/25/23
  • 52 Week Low0.58
  • 52 Week Low Date04/18/24
  • Market Cap88.22M
  • Shares Out151.01M
  • 10 Day Average Volume4.41M
  • Dividend-
  • Dividend Yield-
  • Beta2.29
  • YTD % Change-58.27

RATIOS/PROFITABILITY

  • EPS (TTM)-0.90
  • P/E (TTM)-0.65
  • Fwd P/E (NTM)-0.49
  • EBITDA (TTM)-101.74M
  • ROE (TTM)-538.57%
  • Revenue (TTM)126.325M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-90.02%
  • Debt To Equity (MRQ)-226.38%

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Seres Therapeutics Inc

 

Profile

MORE
Seres Therapeutics, Inc. is a commercial-stage microbiome therapeutics company. It is focused on the development and commercialization of a novel class of biological drugs, which are designed to treat disease by modulating the microbiome to restore health by repairing the function of a disrupted microbiome to a non-disease state. Its lead program, VOWST, is to prevent recurrence of Clostridioides difficile infection (CDI) in patients 18 or older following antibacterial...
Stephen Berenson
Independent Chairman of the Board
Eric Shaff
President, Chief Executive Officer, Director
Marella Thorell
Chief Financial Officer, Executive Vice President
Matthew Henn Ph.D.
Executive Vice President, Chief Scientific Officer
Lisa von Moltke M.D.
Executive Vice President, Chief Medical Officer
Address
200 Sidney St
Cambridge, MA
02139-4218
United States

Top Peers

SYMBOLLASTCHG%CHG
CLSD
Clearside Biomedical Inc
1.32+0.06+4.76%
AFMD
Affimed NV
5.07-0.16-3.06%
LVTX
LAVA Therapeutics NV
2.83-0.11-3.74%
ATRA
Atara Biotherapeutics Inc
0.6917-0.0232-3.2452%
CUE
Cue Biopharma Inc
1.58-0.05-3.07%